FDA approves ‘game-changing’ pancreatic cancer drug - NBC News
FDA approves ‘game-changing’ pancreatic cancer drug NBC News
331 материалов по теме, собраны автоматически из проверенных источников
FDA approves ‘game-changing’ pancreatic cancer drug NBC News
FDA Approves Drug for Pancreatic Cancer in Milestone for Treatment of Deadly Disease WSJ
FDA approves breakthrough drug to treat advanced pancreatic cancer ABC News - Breaking News, Latest News and Videos
FDA approves first-of-its-kind treatment for most common form of pancreatic cancer Scripps News
FDA Approves Rasonque, First-in-Class Targeted Therapy for Metastatic Pancreatic Cancer Cure Today
FDA approves new pancreatic cancer drug expected to usher in new era of treatment STAT
В США успешно испытали вакцину от рака - как Казахстан готовится к новой терапии TengriNews
Лазер против рака: в Сеченовском Университете испытали фотодинамическую терапию для уничтожения опухолевых клеток Сеченовский Университет
The FDA approved two zanidatamab-hrii-based regimens as first-line treatment for adults with unresectable locally advanced or metastatic HER2-positive gastroesophageal adenocarcinoma. Zanidatamab-hrii (Ziihera, Jazz Pharmaceuticals) received approval in combination with fluoropyrimidine- and platinum-containing…
An updated clinical guideline is designed to clarify the settings in which radiation therapy is appropriate for pancreatic cancer and outline how the modality can be integrated safely with other treatments. The guideline — which updates recommendations that American Society for Radiation Oncology (ASTRO) issued in…
Blocking the glycine transporter SLC6A20 restored important brain signaling and improved social, communication, and repetitive behaviors in autism-related mouse models. The treatment also worked in human brain organoids and showed lasting effects in adult mice, suggesting the brain may remain more treatable later in…
Chemotherapy-surviving ovarian cancer cells may release fructose to help neighboring tumor cells loosen, escape, and spread. The discovery suggests that sugary diets and cholesterol-lowering drugs could influence cancer progression, though the effects have not yet been confirmed in patients.